Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.33
-1.55 (-10.39%)
At close: Oct 30, 2026, 4:00 PM EDT
13.32
0.00 (-0.04%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Bioventus Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Bioventus stock has a consensus rating of "Strong Buy" and an average price target of $17.6. The average 1-year stock price forecast is 32.08% higher than the current stock price, while the lowest is $15 (+12.57%) and the highest is $19 (+42.59%).
Price Target: $17.6 (+32.08%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Maintains $18 | Buy | Maintains | $18 | +35.08% | Oct 28, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +12.57% | Aug 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $15 → $19 | Buy | Maintains | $15 → $19 | +42.59% | Aug 17, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $16 → $18 | Buy | Reiterates | $16 → $18 | +35.08% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
604.79M
from 568.09M
Increased by 6.46%
Revenue Next Year
645.57M
from 604.79M
Increased by 6.74%
EPS This Year
0.78
from 0.68
Increased by 14.41%
EPS Next Year
0.92
from 0.78
Increased by 18.25%
EPS and Forward PE are based on non-GAAP adjusted numbers.